Xilio Therapeutics Inc (XLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,529 | -35,036 | -45,396 | -29,109 | -13,265 |
| Depreciation Amortization | 344 | 1,541 | 1,218 | 878 | 497 |
| Accounts payable and accrued liabilities | -1,680 | 152 | -276 | 1,522 | -590 |
| Other Working Capital | -10,864 | 22,050 | 16,881 | 34,432 | 39,247 |
| Other Operating Activity | -614 | 6,301 | 24,579 | 6,778 | 3,089 |
| Operating Cash Flow | $-22,343 | $-4,992 | $-2,994 | $14,501 | $28,978 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -556 | -518 | -423 | -423 | -22 |
| Investing Cash Flow | $-556 | $-518 | $-423 | $-423 | $-22 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 37,257 | 87,775 | 51,909 | 52,194 | 4,832 |
| Other Financing Activity | -1,550 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $35,707 | $87,775 | $51,909 | $52,194 | $4,832 |
| Beginning Cash Position | 139,338 | 57,073 | 57,073 | 57,073 | 57,073 |
| End Cash Position | 152,146 | 139,338 | 105,565 | 123,345 | 90,861 |
| Net Cash Flow | $12,808 | $82,265 | $48,492 | $66,272 | $33,788 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,343 | -4,992 | -2,994 | 14,501 | 28,978 |
| Capital Expenditure | -556 | -518 | -423 | -423 | -22 |
| Free Cash Flow | -22,899 | -5,510 | -3,417 | 14,078 | 28,956 |